None listed
Conditions
Interventions
Medical Device : ? Test Group (Atelocollagen Injection Group): After barbotage guided by ultrasound, lidocaine and atelocollagen are injected.
? Control Group (Lidocaine Injection Group): After ba
Sponsors
The Catholic University of Korea, Eunpyeong St. Mary's Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Selection Criteria ? Adults aged 20 years or older and under 70 years old. ? Patients in whom calcification of 5mm or more is observed on plain radiographs. ? Patients who, if taking concomitant medications continuously during the clinical trial period, have verified prescriptions within the last week and agree to maintain a consistent dose throughout the study period. ? Individuals who have agreed to participate in this study and have provided written consent.
Exclusion criteria
Exclusion criteria: Exclusion Criteria ? Patients with a history of infectious arthritis, rheumatoid arthritis, tumors, or fractures. ? Patients with hypersensitivity. ? Patients with a history of anaphylactic reactions. ? Patients with ongoing autoimmune diseases or a past history of them, either in the patient or their family. ? Patients allergic to grafts. ? Patients allergic to porcine (pig) proteins. ? Patients deemed inappropriate for the trial due to mental illnesses or at the discretion of the trial administrator. ? Patients who have received intra-articular steroid or other injection treatments within a month prior to the decision for the procedure. ? Patients who include oral steroids among their concomitant medications.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Funcional score | — |
Secondary
| Measure | Time frame |
|---|---|
| Range of motion of the shoulder joint;Change of the calcific material by plain radiograph | — |
Countries
Korea, Republic of
Contacts
Public ContactHyungsuk Kim
The Catholic University of Korea, Eunpyeong St. Mary's Hospital
Outcome results
None listed